Clinical outcomes of immunomodulation therapy in immunocompromised patients with severe Covid-19 and high oxygen requirement-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical outcomes of immunomodulation therapy in immunocompromised patients with severe Covid-19 and high oxygen requirement

Published:2024-07-23 Issue:1 Volume:14 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Goldstein Avigayil,Neuberger Ami,Darawsha Yazeed Qassem,Hussein Khetam,Shafat Tali,Grupel Daniel,strahilevitz Jacob,Israel Sarah,Weil Ariel,Ben-Ami Ronen,Elbaz Meital,Najjar-Debbiny Ronza,Bishara Jihad,Shlomai Amir,Landes Michal

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41598-024-68013-6.pdf

Reference34 articles.

1. Gustine, J. N. & Jones, D. Immunopathology of Hyperinflammation in COVID-19. Am. J. Pathol. 191(1), 4–17 (2021).

2. Giamarellos-Bourboulis, E. J. et al. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe 27(6), 992-1000.e3 (2020).

3. van de Veerdonk, F. L. et al. A guide to immunotherapy for COVID-19. Nat. Med. 28(1), 39–50 (2022).

4. Abani, O. et al. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial and updated meta-analysis. The Lancet 400(10349), 359–368 (2022).

5. Kalil, A. C. et al. Baricitinib plus Remdesivir for hospitalized adults with Covid-19. N. Engl. J. Med 384(9), 795–807 (2021).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP